A large number of studies have also demonstrated that, in addition to lung cancer, ANXA1 expression is upregulated in a variety of cancers, including hepatocellular carcinoma (Zhuang et al., 2019), colorectal cancer (Liang and Li, 2021), pancreatic cancer (Novizio et al., 2021), melanoma (Delorme et al., 2021), and endometrial cancers (Aboulouard et al., 2021). Here, ANXA1 is linked to pancreatic neoplasm.